OpenNeedle Ask your own

Question explored with the scientific record

Answered on this page ↓

Suggest dosage for obese 66 year old woman white

Nov 14, 2026 · 6 sources used · OpenNeedle synthesis
The short version: for an obese 66-year-old white woman, expect 2,000 to 4,000 IU of D3 daily to be a reasonable starting point, but the honest answer is that nobody can give you a precise number without your blood level.

Obesity blunts the response. In a pharmacokinetic study, higher-BMI adults absorbed far less vitamin D3 from the same dose than lean adults [2]. In a large community cohort, obese adults needed a mean of 8,000 IU/day to reach the target, versus 6,100 IU for normal-weight adults, and only 65.5% of obese participants reached 100 nmol/L compared with 76.3% of normal-weight ones [1]. Age adds another layer: older adults generally need higher doses than younger ones to reach the same blood level [6].

GroupMean daily dose to reach targetReached 100 nmol/L
Normal BMI6,100 IU76.3%
Overweight7,670 IU74.5%
Obese8,000 IU65.5%

The 4,000 IU/day figure is a reasonable ceiling for unsupervised use. A geriatrics consensus projected that 4,000 IU/day from all sources would get about 92% of older adults to target regardless of obesity, with top-5% blood levels still well below the toxicity threshold [3]. Above that, the safety picture gets murkier: a 3-year trial found hypercalciuria in 23% of adults on 400 to 10,000 IU/day, worse at the high end [4]. One case report describes a 63-year-old woman with sarcoidosis who developed severe hypercalcemia and kidney injury after years of uncontrolled high-dose D3 [5].

The evidence here does not tell you what dose is right for this specific woman. It tells you the direction: obese and older means higher, and the only way to know is to measure her 25(OH)D and retest after 8 to 12 weeks.

My call: start at 2,000 to 4,000 IU of D3 daily, check her blood level first, and adjust from there. Confidence: moderate on the direction, low on the exact number.

Keep digging

Sources used 6

  1. Evaluation of vitamin D3 intakes up to 15,000 international units/day and serum 25-hydroxyvitamin D concentrations up to 300 nmol/L on calcium metabolism in a community setting Dermato-Endocrinology (2017) Thin

    A large community-based assessment of high-dose vitamin D3 supplementation (up to 15,000 IU/day) over 6–18 months in 3,882 adults found that serum 25(OH)D can reach up to 300 nmol/L without perturbing calcium homeostasis or causing toxicity, though BMI influenced the dose needed…

    DOI: 10.1080/19381980.2017.1300213
  2. A pilot-randomized, double-blind crossover trial to evaluate the pharmacokinetics of orally administered 25-hydroxyvitamin D3 and vitamin D3 in healthy adults with differing BMI and in adults with intestinal malabsorption The American Journal of Clinical Nutrition (2021) Thin

    A pilot, randomized, double-blind crossover trial comparing pharmacokinetics of 900 μg oral vitamin D3 versus 25-hydroxyvitamin D3 (25(OH)D3) in healthy adults with differing BMI and in adults with intestinal malabsorption, showing that 25(OH)D3 generally has greater/better bioa…

    DOI: 10.1093/ajcn/nqab123
  3. Recommendations Abstracted from the American Geriatrics Society Consensus Statement on Vitamin D for Prevention of Falls and Their Consequences Journal of the American Geriatrics Society (2013) other Strong

    A geriatrics workgroup recommends older adults—especially frail ones—reach 25(OH)D ≥30 ng/mL (75 nmol/L) via ≥1,000 IU/d vitamin D with calcium (≈4,000 IU/d total intake) in community and institutional settings to reduce falls and fractures, with no routine 25(OH)D testing neede…

    DOI: 10.1111/jgs.12631
  4. The complex relationship between vitamin D and kidney stones: balance, risks, and prevention strategies Frontiers in Nutrition (2024) narrative review Strong

    Vitamin D deficiency and excess may both raise kidney stone risk via calcium–phosphorus metabolism, yet trial evidence on supplementation is contradictory and moderate doses under 4,000 IU/day appear generally safe.

    DOI: 10.3389/fnut.2024.1435403
  5. Sarcoidosis Case with Acute Renal Failure, Nephrolithiasis, and Hypercalcaemia After Uncontrolled D3 Vitamin Supplementation EMJ Nephrology (2025) primary study Strong

    A 63-year-old woman with sarcoidosis developed severe hypercalcaemia, nephrolithiasis, and acute kidney injury after 3 years of uncontrolled vitamin D3 supplementation, and recovered renal function over 9 months of corticosteroid therapy.

    DOI: 10.33590/emjnephrol/nnyo5340
  6. Correcting poor vitamin D status: Do older adults need higher repletion doses of vitamin D 3 than younger adults? Molecular Nutrition & Food Research (2010) narrative review Strong

    Reviewing vitamin D3 repletion studies, the authors concluded older adults generally require higher supplementary doses than younger adults to reach 25(OH)D of 75 nmol/L, with daily doses above 2000 IU in younger and 5000 IU in older adults.

    DOI: 10.1002/mnfr.200900536

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →